RE:RE:RE:RE:New Press Release - Kane Biotech Announces Health Canada Approval of revyve(TM) Antimicrobial Wound GelThis is (2) excerpts from Kane's press release from last January regarding the 'wound gel spray' product;
''Kane Biotech Inc. (TSX-V:KNE OTCQB:KNBIF) (the “Company” or “Kane Biotech” or “Kane”) announces that it has filed a patent on its revyve™ Antimicrobial Wound Gel Spray, a follow-on product to its FDA 510(k) cleared revyve™ Antimicrobial Wound Gel.... ''
''Kane is in the final stages of development of this product which is still pending FDA clearance.''
So, the way I understand this is;
1. It's an approve product since it's a follow-on product to it's already approved wound gel;
2. It can't be commercialized until the FDA provide the go-ahead which to my knowledge we never got or, maybe we did and it was not announced or released by Kane.
Good times ahead...
GLTA!